SRI INTERNATIONAL

Federal contract awards won by SRI INTERNATIONAL (UEI SRG2J1WS9X63), 2006–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

281
awards
48
expiring in 12 months
8
agencies

Teaming snapshot

teams under 25 primes · primes 153 subs.

From subcontract reports primes file with USAspending/FSRS.

How their work has changed

Their work has shifted somewhat over the last two years.

Biggest change: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715) went from 35% of their contracts to 42%.

Industry (NAICS)2 years beforeLast 2 years
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)35%42%
Administrative Management and General Management Consulting Services (541611)34%29%
Pharmaceutical Preparation Manufacturing (325412)0%4%
Other Computer Related Services (541519)3%0%
Research and Development in Biotechnology (541711)4%7%

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 18, 2026. Shown only for companies with at least 5 contracts in each period.

Where their reported work happens

StateReported subawards
CA79
NY13
VA13
MA10
NJ9
MD6
TX5
PA5
WA4
FL3
IL3
OR3

Place of performance on subcontract reports filed with USAspending/FSRS.

Category award history

385 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY LLC took Department of Defense 541715 work from SRI INTERNATIONAL (Nov 15, 2026).

Awards

NICHD: R&D: PRECLINICAL DEVELOPMENT OF ANDROGEN PROGESTIN (PDAP): NON-SEVERABLE
Department of Health and Human Services · $596,758 · Sep 30, 2026
NICHD: R&D SERVICES: BIOLOGICAL TESTING FACILITY: SEVERABLE
Department of Health and Human Services · $540,464 · Sep 30, 2026
"EO 14398"; IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG PRODUCTS (TRND 3)
Department of Health and Human Services · No current value reported · Jul 3, 2026
NICHD: R&D: PRECLINICAL, MANUFACTURING, AND STABILITY STUDIES: NON-SEVERABLE
Department of Health and Human Services · $1,493,449 · Jun 1, 2026
NICHD: R&D: SMALL MOLECULE X-RAY CRYSTALLOGRAPHY: NON-SEVERABLE
Department of Health and Human Services · $348,574 · May 26, 2026
NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP)
Department of Health and Human Services · No current value reported · May 4, 2026
TO AWARD TASK ORDER C03
Department of Health and Human Services · $721,962 · Feb 20, 2026
8511911911!R&D-OTHER: ADVANCED DEVELOPM
Department of Defense · $3,523,374 · Feb 10, 2026
PHARMACOKINETICS OF LONG-ACTING PREPARATIONS OF ANTITUBERCULAR DRUGS IN RODENTS
Department of Health and Human Services · $830,604 · Sep 30, 2025
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MEDICAL COUNTERMEASURES (MCMS)
Department of Health and Human Services · $16,236,839 · Sep 30, 2025
SBIR-STTR DATA ANALYTICS DUE DILIGENCE (SERVICES)
National Science Foundation · $3,622,963 · Sep 29, 2025
INTERVENTIONAL AGENTS CHEMISTRY SERVICES
Department of Health and Human Services · No current value reported · Sep 15, 2025
INTERVENTIONAL AGENTS SAFETY AND PHARMACOKINETICS SERVICES
Department of Health and Human Services · No current value reported · Sep 15, 2025
MICROSYSTEMS INDUCED CATALYSIS (MICA)
Department of Defense · $5,598,968 · Aug 28, 2025
PROVABLY WEIRD NETWORK DEPLOYMENT AND DETECTION (PWND2)
Department of Defense · $3,616,131 · Aug 1, 2025